+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Valproic acid free fraction in epileptic children under chronic monotherapy



Valproic acid free fraction in epileptic children under chronic monotherapy



Therapeutic Drug Monitoring 5(2): 197-200



The total and free (nonprotein-bound) concentration of valproic acid (VPA) was determined in plasma samples collected at two different times of the day (before the morning dose and 3 h later) in 62 epileptic children receiving maintenance single-drug therapy with sodium valproate. Both the total and the free concentrations were lower in the early than in the late morning samples (total VPA: 394.4 +/- 150.0 vs. 556.9 +/- 175.2 mumol/L; free VPA: 20.1 +/- 11.1 vs. 31.3 +/- 17.4 mumol/L). The average free fraction of the drug was also lower in the early morning (4.8 +/- 1.3 vs. 5.4 +/- 1.6%, p less than 0.001). At both sampling times, the free fraction was positively correlated (p less than 0.01) with the total concentration. Evidence is presented that, at equal total plasma VPA concentration, the free fraction of the drug is significantly (p = 0.01) higher in the early than in the late morning samples. The rise in plasma free fatty acids (acting as displacing agents) after the overnight fast is probably responsible for this difference in free fraction. The implications of these findings with respect to the monitoring of free plasma VPA levels are discussed.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 044936968

Download citation: RISBibTeXText

PMID: 6410546

DOI: 10.1097/00007691-198306000-00008


Related references

Protein binding of valproic acid in epileptic children under chronic monotherapy. Japanese Journal of Pharmacology 49(SUPPL): 342P, 1989

Free plasma fraction of valproic acid in epileptic patients. Drug Investigation. 5(2): 108-113, 1993

Estimation vs determination of fraction of free drug of phenytoin , valproic acid and carbamazepine in patients on monotherapy. Clinical Chemistry & Laboratory Medicine 37(SPEC SUPPL ): S317, 1999

Steady-state pharmacokinetics of valproic acid in epileptic children and adolescents on monotherapy and bitherapy with carbamazepine and vigabatrin. Journal of the Neurological Sciences 150(SUPPL ): S166, 1997

Blood ammonia levels in epileptic children on 2 dose ranges of valproic acid monotherapy: a cross-sectional study. Journal of Child Neurology 26(1): 109-112, 2011

Concentrations of zonisamide in serum, free fraction, mixed saliva and cerebrospinal fluid in epileptic children treated with monotherapy. Japanese Journal of Psychiatry and Neurology 47(2): 291-292, 1993

Genetic polymorphisms and valproic acid plasma concentration in children with epilepsy on valproic acid monotherapy. Seizure 51: 22-26, 2017

Carbamazepine Verses Valproic Acid as Monotherapy in Epileptic Patients. Journal of the College of Physicians and Surgeons--Pakistan 28(5): 357-360, 2018

Effects of coadministered antiepileptic drugs on free fractions of phenobarbital and valproic acid in epileptic children. Kobe Journal of Medical Sciences 32(5): 141-149, 1986

The diurnal fluctuations in free and total serum valproic acid concentration at steady state in epileptic children. Journal of Pharmacy & Pharmacology 38(SUPPL): 11P, 1986

Investigations on the clinical efficacy and adverse effects of valproic acid monotherapy in epileptic patients. Nervenarzt 59(5): 286-295, 1988

The effect of chronic carbamazepine, valproic acid and phenytoin medication on the periodontal condition of epileptic children and adolescents. Functional Neurology 11(4): 187-193, 1996

Validation and chronic usefulness of a single dose prediction model to forecast the total and free steady state concentrations of valproic acid in epileptic patients. Epilepsia 25(5): 643, 1984

Free fraction of valproic acid: in vitro time-dependent increase and correlation with free fatty acid concentration in human plasma and serum. Epilepsia 24(1): 65-73, 1983

Pharmacokinetics of total and free valproic acid during monotherapy in infants. Journal of Neurology 238(6): 315-319, 1991